Your Top 50 most-cited badge

A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.

The article

Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up

Yves Fradet, Joaquim Bellmunt B, David J. Vaughn, J L Lee, Lawrence H. Fong, Nicholas J. Vogelzang and 14 more

Rank
23 of 4,622
Percentile
top 0.5%
Where
Annals of Oncology, 2019
Citations
479

From the 2019 list, OpenAlex counts as of 2026-10-29.

Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.